期刊文献+

慢病毒介导的生长抑素shRNA对BHK-21细胞生长的影响

The effects of lentviral-directed shRNA targeting somatostatin on cell proliferation of BHK-21 cells
原文传递
导出
摘要 采用慢病毒介导的shRNA沉默细胞自身生长抑素(SS)的表达,同时,以pcDNA3.1-SS(pSS)真核表达载体转染细胞作为阳性对照,研究SS对BHK-21细胞的抑制增殖作用,同时观察SS是否具有促进细胞凋亡的作用。MTT法绘制细胞生长曲线可知,pSS转染细胞的生长受到明显抑制,抑制效率为9.63%(P<0.05);而LV-sh2组细胞的生长密度是对照组细胞的117.33%(P<0.05),表明SS对细胞的增殖具有抑制作用。流式细胞检测细胞凋亡表明,pSS转染组和LV-shRNA感染组凋亡细胞含量分别是对照组凋亡细胞含量的1.97倍(P<0.05)和24.30%(P<0.05),表明SS通过诱导细胞凋亡发挥抑制细胞增殖的作用。本研究为SS及其类似物作为治疗药物的进一步开发应用提供了理论依据。 Several lines of evidence implicated that somatostatin(SS) is commonly expressed in many cells and has the anti-proliferative effects of cell growth,but the functions of the endogenous SS on the proliferation and apoptosis of normal cells are still largely Lrnknown. In this research, the endogenous SS expression was down-regulated in BHK-21 cells using a Lentiviral-shRNA(Lv) to examine whether it would have an effect on cell proliferation with the pcD- NA3.1-SS(pSS) transfected cells as the positive Control. Cell growth curve measured by using the MTT assay showed that higher levels of SS inhibit the cell growth ability significantly(9.63%, P〈0.05). Reversely, lowering SS could stimulate the cell growth ability(17.33% ,P〈0.05). In addition,the apoptosis of cells detected by flow cytometry indicated that lower percents (24. 30 %, P〈 0. 05) of apoptosis cells were observed relative to controlled BHK-21 cells, and higher percents were showed in pSS transfected cells(1.97 folds,P〈0.05), which indicated that the anti-proliferative function of SS is via the induction of the cell apoptosis. This research gets theoretical foundation for SS and its analogs used as a potential drug of inhibitor in humans or animals.
出处 《中国兽医学报》 CAS CSCD 北大核心 2011年第7期1003-1006,共4页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目(30771572) 吉林大学农学部人才引进启动基金
关键词 生长抑素 慢病毒载体 细胞增殖 细胞凋亡 somatostatin lentiviral vector cell proliferation cell apoptosis
  • 相关文献

参考文献11

  • 1Brazeau P,Vale W,Burgus R. Hypothalamic polypep tide that inhibits the secretion of immunoreactive pitu itary growth hormone[J].Science, 1973,179 (68) : 77- 79.
  • 2Guo M, Hay B A. Cell proliferation and apoptosis[J]. Curr Opin Cell Bio1,1999,11(6):745-752.
  • 3Okada T, Iwamoto A, Kusakabe K, et al. Perinatal development of the rat kidney~ proliferative activity and epidermal growth factor[J]. Biol Neonate, 2001, 79 (1) :46-53.
  • 4Okada T, Iwamoto A, Mukamoto M, et al. Perinatal development of the rat kidney: Apoptosis and epidermal growth factor[J]. Congenit Anom (Kyoto),2003,43 (3) : 161-167.
  • 5Nagy P, Arndt D J ,Jovin T M. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbBl) and induce apoptosis in erbBl-overexpressing cells [J]. Exp Cell Res,2003,285(1) :39-49.
  • 6Mautino M R. Lentiviral vectors for gene therapy of HIV-1 infection[J]. Curr Gene Ther, 2002,2 (1) : 23-43.
  • 7苏玲 刘学荣 董文教 等.接种街度对BHK21细胞在MEM-SLM培养液中生长的影响.中国兽医科学,2007,:1035-1037.
  • 8Bauer W, Briner U, Doepfner W, et al. SMS2-1-995 : a very potent and selective octapeptide analogue of sore atostatin with prolonged action[J]. Life Sci, 1982,31 (13) : 1133-1140.
  • 9Pinski J, Halmos G, Yano T, et al. Inhibition of growth of MEN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin releasing-peptide antagonist ( RC-3095 ) and somatostatin analogue RC-160[J]. lnt J Cancer, 1994,57 (4) : 574- 580.
  • 10朱晓燕,张艳,张钦宪.siRNA对胃癌细胞系BGC-823生长抑素基因表达的抑制效应[J].解剖学杂志,2006,29(4):426-429. 被引量:2

二级参考文献24

  • 1Schinder M, Humphrey PP. Localization of the Somatostatin sst2 (a) receptor in human cerebral cortex. Hippocampus and cerebellum [J]. Neuroreport, 1998, 9: 521-525.
  • 2Patel YC. Molecular pharmacology of somatostatin receptor subtypes [J]. J Endocrinol Inuest, 1997, 20: 348-367.
  • 3Westlin JE, Tiensu JE, Anlstrom H, et al. A new diagnostic method: somatostatin receptor scintigraphy of neuroendocrine tumors [J]. Antibody, 1992, 5: 367-383.
  • 4Sreedharan SP, Kodama KT, Peterson KE, et al. Distinct subsets of somatostatin receptors on cultured human lymphocytes [J]. J BiolChem, 1989, 264: 949-953.
  • 5Reubi JC, Horisberger U, Essed CE, et al. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas [J]. Gastroenterology, 1988, 95: 760-763.
  • 6Eijek CH, Krenning EP, Bootsma A, et al. Somatostatin receptor scintigraphy in primary breast cancer [J]. Lancet,1994, 343: 640-643.
  • 7Denzler B, Reubi JC. Expression of somatostarin receptors in peritumoral veins of human tumors [J]. Cancer, 1999, 85:188-198.
  • 8Froidevaux S, Hintermann E, Torok M, et al. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment [J]. Cancer Res, 1999, 59 (15): 3652-3657.
  • 9Eriksson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook [J].Ann Oncol, 1999, 10 (Supp1-2): S31-38.
  • 10Brazeaup V, Burgus R, Ling N, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone [J]. Science, 1973, 179: 77-79.?A

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部